Insider · CIK 0001270521

Kolluri Krishna Kittu

CIK 0001270521 Name as filed on the most recent filing

Filed as Kolluri Krishna Kittu (118)

224 transaction lines · from 118 filings · filed 2003-12-01 to 2022-08-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

131 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2015-06-02 S, Open-market sale Tesaro, Inc.TSRO 2 lines 7,644, disposed Open Form 4 filing 0001181431-15-007920
2015-02-04 P, Open-market purchase Tracon Pharmaceuticals, Inc.TCON 5,000,000, acquired Open Form 4 filing 0001181431-15-002007
2015-01-30 P, Open-market purchase Zosano Pharma CorpZSAN 258,027, acquired Open Form 4 filing 0001181431-15-001720
2014-12-29 S, Open-market sale Ardelyx, Inc.ARDX 3 lines 5,364, disposed Open Form 4 filing 0001181431-14-039786
2014-12-23 P, Open-market purchase Interleukin Genetics IncILIU 1,992,857, acquired Open Form 4 filing 0001181431-14-039778
2014-12-10 P, Open-market purchase Trevena IncTRVN 4,000,000, acquired Open Form 4 filing 0001181431-14-038451
2014-10-08 P, Open-market purchase Dermira, Inc.DERM 1,105,792, acquired Open Form 4 filing 0001181431-14-034007
2014-08-29 S, Open-market sale Sunesis Pharmaceuticals IncSNSS 87,070, disposed Open Form 4 filing 0001181431-14-030574
2014-08-28 S, Open-market sale Sunesis Pharmaceuticals IncSNSS 1,154,846, disposed Open Form 4 filing 0001181431-14-030574
2014-08-27 S, Open-market sale Sunesis Pharmaceuticals IncSNSS 884,811, disposed Open Form 4 filing 0001181431-14-030574
2014-08-22 S, Open-market sale Tableau Software IncDATA 292,073, disposed Open Form 4 filing 0001181431-14-029993
2014-08-15 S, Open-market sale Epizyme, Inc.EPZM 3 lines 23,807, disposed Open Form 4 filing 0001181431-14-029540
2014-08-15 S, Open-market sale Epizyme, Inc.EPZM 3 lines 23,807, disposed Open Form 4 filing 0001181431-14-029541
2014-08-15 S, Open-market sale Cvent IncCVT 3 lines 13,240, disposed Open Form 4 filing 0001181431-14-029555
2014-08-12 S, Open-market sale Sunesis Pharmaceuticals IncSNSS 240,190, disposed Open Form 4 filing 0001181431-14-029001
2014-08-08 S, Open-market sale Sunesis Pharmaceuticals IncSNSS 4,468,568, disposed Open Form 4 filing 0001181431-14-029001
2014-08-06 P, Open-market purchase Loxo Oncology, Inc.LOXO 2,999,997, acquired Open Form 4 filing 0001181431-14-028430
2014-07-22 P, Open-market purchase Roka BioScience, Inc.ROKA 4,599,996, acquired Open Form 4 filing 0001181431-14-027155
2014-06-24 P, Open-market purchase Ardelyx, Inc.ARDX 7,146,188, acquired Open Form 4 filing 0001181431-14-025055
2014-06-06 S, Open-market sale Hyperion Therapeutics IncHPTX 3 lines 3,263, disposed Open Form 4 filing 0001181431-14-023156
2014-05-14 S, Open-market sale Tableau Software IncDATA 81,846, disposed Open Form 4 filing 0001181431-14-019669
2014-04-22 P, Open-market purchase TriVascular Technologies, Inc.TRIV 6,999,996, acquired Open Form 4 filing 0001181431-14-016851
2014-03-05 S, Open-market sale Tableau Software IncDATA 2 lines 458,053, disposed Open Form 4 filing 0001181431-14-010968
2014-02-05 P, Open-market purchase Trevena IncTRVN 3,306,870, acquired Open Form 4 filing 0001181431-14-005688
2014-01-21 S, Open-market sale Cvent IncCVT 6,030,989, disposed Open Form 4 filing 0001181431-14-003491
2014-01-16 S, Open-market sale Cvent IncCVT 40,206,910, disposed Open Form 4 filing 0001181431-14-003131
2014-01-15 P, Open-market purchase Glycomimetics IncGLYC 4,100,000, acquired Open Form 4 filing 0001181431-14-002531
2013-11-20 S, Open-market sale Tableau Software IncDATA 72,298,403, disposed Open Form 4 filing 0001181431-13-059890
2013-11-15 P, Open-market purchase Epizyme, Inc.EPZM 2 lines 979,454, acquired Open Form 4 filing 0001181431-13-059379
2013-11-14 P, Open-market purchase Epizyme, Inc.EPZM 3 lines 7,018,527, acquired Open Form 4 filing 0001181431-13-059379
2013-11-13 S, Open-market sale Tableau Software IncDATA 423,774,930, disposed Open Form 4 filing 0001181431-13-059101
2013-11-12 S, Open-market sale Channeladvisor CorpECOM 2 lines 35,744,281, disposed Open Form 4 filing 0001181431-13-058742
2013-09-11 S, Open-market sale Groupon, Inc.GRPN 2 lines 5,929, disposed Open Form 4 filing 0001181431-13-048752

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 35
  • Open-market sale 96
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. KOLLURI KRISHNA KITTU, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001270521

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.